Three segments, ~$185B market cap, ~$24B FY25 revenue — the operating-system compounder as it stands in 2026

Danaher Corporation (NYSE:DHR) today is a focused life-sciences platform generating approximately $24 billion of FY2025 revenue across three segments: Biotechnology (~27% of revenue), Life Sciences (~29%), and Diagnostics (~44%). Aggregate FY2025 adjusted EBIT margin runs at approximately 25%, adjusted EBITDA margin approximately 28-30%, and reported ROIC in the low-to-mid teens. Market capitalization stands at approximately $185B; net debt is approximately $14B, taking enterprise value to approximately $200B. The company employs approximately 63,000 people across roughly 150 sites in 60 countries. This is the post-Veralto Danaher — a refocused life-sciences platform after the 2023 spinoff of water-quality and product-identification businesses.

The distinguishing framing this memo places on Danaher is that it is the exemplar of one specific compounder archetype: the operating-system compounder. That archetype is distinct from the Berkshire model of owner-discretion capital allocation with a light operating touch, distinct from the Constellation Software model of permanent-capital VMS aggregation with a strict hurdle-rate discipline, and distinct from the LVMH model of brand-portfolio compounding through maison assembly. Danaher's specific mechanism is a codified operating system — the Danaher Business System (DBS) — installed at every acquired target within a 100-day standard. The compounding shows up in the tape because the operating discipline is durable across CEOs, business cycles, and portfolio reshapings. Section 11 develops the four-archetype taxonomy in detail.

Every practitioner reader needs the four-decade shape of the Danaher record before the operating detail makes sense. Tables 1a, 1b, and 1c below anchor the record: the current segment structure, the four-decade compounding trajectory from the 1984 DMG acquisition to today, and the current standing of the four Danaher-lineage entities (parent Danaher plus the three spinoffs). The claim is not that the Rales brothers invented anything. The claim is that they installed a specific operating technology (DBS) inside a specific capital-allocation discipline (patient serial acquisition), held it in place for forty consecutive years, and reproduced the mechanism across enough targets that the compounding shows up in the tape.

Table 1a — Danaher today (post-Veralto structure, FY2025)

Source: Danaher FY2025 Form 10-K (filed February 2026). Figures rounded to the nearest ~$0.1B for clarity.

Table 1b — The four-decade Danaher-lineage compounding record (illustrative, USD)

Source and reconciliation. Institute reconstruction from Danaher Corporation historical annual reports (1984-2025); Fortive, Envista, and Veralto post-spin filings; press releases documenting major acquisitions and spin transactions; Bloomberg market-cap history for the four Danaher-lineage entities. All figures are illustrative directional; the specific magnitude should be read as practitioner shorthand for one of the four or five most impressive multi-decade acquisition-compounding records in public equity.

Table 1c — Danaher-lineage universe (4-entity aggregate)

Source: Company FY2025 10-Ks; market caps approximate at July 2026.

Steve and Mitchell Rales, DMG, and the 1984 reverse merger that created Danaher

Steven M. Rales (born 1951) and Mitchell P. Rales (born 1956) are the second-generation entrepreneurs who founded Danaher. They are the sons of Norman Rales, a Washington, DC-area real-estate developer of Russian-Jewish descent, and Ruth Rales. Both brothers attended Miami University in Ohio; Mitchell also did graduate work at Harvard Business School. In their twenties and early thirties the brothers began a series of real-estate and small-business acquisitions in the Washington-Baltimore corridor, building an early set of holdings that included the Master Shield vinyl siding business, a stake in what would eventually become part of the DMG MORI machine-tool operator, and Chicago Pneumatic (industrial tools). These early acquisitions established the operating rhythm that would become the Danaher method: buy the ugly business at a defensible price, install operational rigor, hold forever, redeploy the cash flow into the next acquisition.

The founding transaction that created Danaher was executed in 1984 through a reverse merger with a small NYSE-listed real-estate investment vehicle called Diversified Mortgage Investors (DMI), which the brothers renamed after the Danaher River in Montana — a river the brothers had fished as boys during family trips west. Public accounts note the Rales brothers were unusually deliberate about the name selection: they wanted something evocative of the American West, something that had nothing to do with the specific business they intended to build, and something that would let them position the company as an operating platform rather than a specific industrial identity. Danaher River is a tributary of the North Fork of the Flathead River in northwestern Montana. The name has stuck for forty-two years.

The early operating philosophy through the mid-1980s was described in interviews and in the earliest annual reports as: invest in what's ugly, apply operational rigor, hold forever. The Rales brothers acquired what would today be called industrial small-caps at prices that reflected under-managed operating discipline — Matco Tools, Delta Consolidated Industries, Chicago Pneumatic, Jacobs Vehicle Systems, and a series of specialty industrial businesses. The record from 1984 through approximately 1989 is opportunistic and cash-flow-driven; the compounding-machine identity develops later, when DBS is formalized. But even the earliest Rales acquisitions demonstrated three enduring features: patient sourcing, non-consensus deployment (the brothers repeatedly bought at moments when others were selling), and long-hold discipline.

Table 2a — The 1984-1990 founding era

Source: Danaher Corporation historical annual reports 1984-1991; George Koenigsaecker, "Leading the Lean Enterprise Transformation" (2009); Institute reconstruction of the DBS-founding timeline.

Table 2b — Rales brothers biographical milestones

Source and reconciliation. Danaher Corporation proxy statements 2000-2025, Fortive proxy statements, publicly available biographical references, Forbes and Bloomberg profiles of the Rales brothers.

Reclusive operators, decentralization, and permanent-capital orientation

Steven and Mitchell Rales are famously reclusive. The brothers have given only a handful of long-form interviews in four decades, most notably a 1997 Wall Street Journal profile titled "The Reclusive Rales Brothers," a 2020 Barron's profile on Steve Rales post-chairman role, and a series of Glenstone Museum interviews Steve Rales has given in the context of the museum rather than Danaher. The written record from which their operating philosophy can be reconstructed is therefore the corpus of Danaher shareholder letters (particularly the 2001-2014 Culp-era letters, which reflect the discipline the Rales brothers set), the earliest Danaher annual reports, and a small number of published board communications. This section synthesizes that record rather than fabricating attributed quotes. Where the direct record is thin, the description is stated in terms of the effects — the operating discipline that shows up in what Danaher actually did — rather than as invented statements.

Decentralization. The Rales brothers' first operating conviction is that operating businesses must be run by the operators closest to the customer. Danaher business units have historically operated with a high degree of autonomy. Segment presidents own their P&Ls, make their own hiring decisions, run their own operating cadences, and are compensated on segment-level performance. The center imposes DBS (the operating system) and capital allocation (which businesses grow, which shrink, which acquisitions close), but does not impose product decisions, pricing decisions, or day-to-day operating choices. This decentralization is a specific inheritance from the Rales brothers' first decade of small-business ownership, when the brothers themselves were physically dispersed across multiple businesses and could not micro-manage.

Capital allocation as the primary CEO job. The Rales brothers' second operating conviction is that capital allocation — not operations, not strategy, not marketing — is the single most important job of the CEO. The written record on this is unusually clear: Steve Rales served as executive chairman from 1984 through 2016, thirty-two consecutive years, and during that period his personal focus was almost exclusively capital allocation: which acquisitions to close, at what price, at what post-close operating cadence, and when to divest or spin. The operational CEOs beneath him (George Sherman 1990-2001; Larry Culp 2001-2014; Tom Joyce 2014-2020; Rainer Blair 2020-present) ran the operations under DBS discipline. This division of labor — owner-chairman on capital allocation, professional CEO on operations — is the Rales' most durable structural contribution.

Spend other people time, not our own. A phrase that appears in Rales-era interviews and Culp-era shareholder letters is the notion that the CEO's job is to build a system in which good decisions are made repeatedly by others, not to make each decision personally. The DBS system is the specific expression of this philosophy: rather than the CEO personally auditing each acquisition, the DBS Office — a dedicated internal cadre of DBS-trained coaches — is dispatched to install the operating cadence at each newly acquired target. The CEO's time is preserved for capital allocation. The system does the operational integration. This is the specific mechanism by which Danaher scales acquisition integration without dilution of quality.

Non-consensus deployment. The Rales brothers have repeatedly made large capital deployments at moments when the broader market has been risk-averse. The Beckman Coulter acquisition (2011, $6.8B, closed during the still-fragile post-GFC recovery), the Pall Corporation acquisition (2015, $13.8B, closed when industrial multiples were compressed), and the Cytiva carve-out from GE (2020, $21.4B, closed in the early months of COVID with GE under maximum operational duress) all share a common feature: they were closed at moments when the price reflected the seller's need for liquidity rather than the asset operating quality. This is the Rales' capital-allocation signature.

Permanent-capital orientation. The Rales brothers have never used Danaher balance sheet as a trading vehicle. Acquisitions are made to be held. When the portfolio is pruned, the mechanism is a spinoff to shareholders, not a sale to a strategic or a sponsor — and even after the spin, the Rales brothers and their family holdings continue to own material stakes in the spun entity. Fortive (2016) was spun to Danaher shareholders; Envista (2019) was spun to Danaher shareholders; Veralto (2023) was spun to Danaher shareholders. In each case, the operating discipline (DBS-branded FBS, EBS, VES) was carried out with the spun entity. This is the specific mechanism by which Danaher compounding is preserved across portfolio reshapings.

Table 3a — Steven Rales operating role evolution

Source: Danaher Corporation annual proxy statements 1990-2025; press coverage of the 2016 spin and successor era.

DBS as an operating system — origins, pillars, the 100-day integration, and forty years of acquisition compounding

DBS is the codified operating system that converts each Danaher acquisition from a portfolio holding into a compounder. Its origins trace to 1988, when George Koenigsaecker, a former HON Industries executive who had studied the Toyota Production System (TPS) firsthand under Taiichi Ohno's disciples, joined Jacobs Vehicle Systems — then a Danaher subsidiary manufacturing Jake Brake engine retarders. Koenigsaecker brought a small team of TPS-trained practitioners to Jacobs and, over 1988-1990, installed the core TPS toolkit: kaizen (continuous improvement events), standard work, value stream mapping, andon (line-stop authority), and single-minute exchange of die (SMED). Danaher early leadership, including the Rales brothers and the operational CEOs, recognized that what was working at Jacobs could be systematized across all of Danaher operating units. Between 1989 and 1991 the methodology was formalized as the Danaher Business System with a small dedicated internal team — the DBS Office — and a formal consulting relationship with Shingijutsu, the Japanese consultancy that had trained many original Toyota kaizen practitioners.

By approximately 1993, DBS was the standard operating rhythm at every Danaher business, and DBS installation had become the standard first act of every acquisition integration. The 100-day standard — every acquired target on DBS operating rhythm within 100 days of close — was formalized in the mid-to-late 1990s and has held ever since. Over the next thirty years DBS extended from a shop-floor toolkit to a full white-collar-and-M&A operating system, absorbing tools like Voice of the Customer (VoC), Policy Deployment (Hoshin Kanri) with its distinctive X-matrix cascade, and the Problem-Idea-Test (PIT) hypothesis-testing framework. DBS today is a stack of approximately 60-70 discrete tools organized under seven pillars.

Table 4a — The seven DBS pillars

Source: Institute practitioner reconstruction from Danaher investor presentations 2018-2025; George Koenigsaecker, "Leading the Lean Enterprise Transformation" (2009); Danaher shareholder letters 2001-2020.

Table 4b — The 100-day integration playbook

Source: Danaher investor day presentations 2019-2025; Danaher DBS Office public communications; Institute practitioner reconstruction of the 100-day playbook.

Table 4c — Danaher acquisitions by decade (illustrative summary)

Source: Baratelli Institute Danaher acquisitions living reference (87 rows, updated through July 2026); Danaher 10-K acquisition disclosures 1984-2025; press releases.

Table 4d — The six landmark acquisitions ranked by transformative impact

Source: Danaher acquisition press releases and 10-K disclosure; Baratelli Institute Danaher acquisitions living reference. Purchase prices are as announced (enterprise value inclusive of assumed debt).

Table 4e — Landmark Danaher acquisition IRR history (Institute reconstruction)

Source: Individual acquisition IRRs are Institute reconstructions from segment-level disclosure and Danaher management earnings-call commentary. Danaher does not disclose per-deal returns.

The three-way comparison every operations executive wants

Practitioners regularly confuse DBS with Six Sigma and with the Toyota Production System (TPS). All three share a common intellectual lineage in the post-WWII quality movement — W. Edwards Deming, Joseph Juran, and Taiichi Ohno — and all three deploy overlapping toolkits (statistical process control, root-cause analysis, standard work). But the three systems answer different questions and fit different institutional contexts. This section provides the three-column comparison that every operations executive comparing methodologies wants.

Table 5a — DBS vs Six Sigma vs Toyota Production System

Source: Institute practitioner reconstruction. Six Sigma historical dates: Bill Smith at Motorola 1986; Jack Welch GE program launched 1995. TPS historical: Taiichi Ohno tenure at Toyota 1948-1975; classic TPS reference is Ohno "Toyota Production System" (1988 English edition).

Table 5b — A one-sentence summary of each

The operator toolkit — seven printable templates

This section provides the seven core DBS practitioner templates in table form. Each is also included as its own tab in the companion Baratelli_Danaher_DBS_Toolkit.xlsx for use as a printable one-page form at the operator level. The seven templates are the operating-executive onsite toolkit: VVC exercise, PIT template, Kaizen event planning, Gemba walk, Root-cause 5 Whys, Policy deployment X-matrix, and GM readiness assessment. Together they are the practitioner-grade minimum of what operating in a DBS environment looks like day-to-day.

Table 6a — VVC (Value Value Chain) exercise — sample output

Read: This is a value-value-chain map with cost overlay. It identifies eight kaizen opportunities (steps 1, 2, 4, 6 are the biggest wait-time reducers). The 12-month backlog would target VA time from 21.5% to 45% and lead time from 8 hours to 3 hours — both achievable with 6-8 targeted kaizen events.

Table 6b — PIT (Problem, Idea, Test) template structure

Table 6c — Kaizen event 5-day agenda

Table 6d — Gemba walk observation prompts

Table 6e — Root-cause 5 Whys sample

Table 6f — Policy Deployment X-matrix structure

Table 6g — GM readiness 10-dimension framework

These tools were forged in the field over three decades. Section 7 traces how one operator — Larry Culp — took them to industrial scale as Danaher CEO from 2001 to 2014.

Culp scaled DBS from an operating tool to a strategic weapon

H. Lawrence Culp Jr. (born May 29, 1963) joined Danaher in 1990 at age 27 after earning his MBA from Harvard Business School. He rose through the operating ranks — VP of the Danaher Business System Office, president of Danaher's Environmental Group, president of Danaher's Motion Group — before being named CEO in May 2001, succeeding George Sherman. Culp was 37 at the time of his appointment, then one of the youngest CEOs of any S&P 500 company. His tenure ran from 2001 to March 2014, when he stepped down and was succeeded by Tom Joyce. During Culp's thirteen-year run, Danaher revenue grew from $3.8B to $19.9B (a 5.2x increase), and market capitalization grew from approximately $5B to approximately $50B (a 10x increase). Under any reasonable framing, this is one of the strongest thirteen-year CEO records in twenty-first-century American public equity.

The Culp record is not, however, a story of one big idea. It is a story of the disciplined application of DBS at increasing scale, combined with an aggressive but disciplined M&A cadence and a willingness to pivot the portfolio when Culp and the Rales brothers concluded that the return profile of the industrial segments had degraded relative to the life-sciences opportunity. The Culp-era acquisitions include a series of platform-defining transactions that established Danaher's life-sciences identity and demonstrated that DBS could integrate businesses at increasingly large deal sizes.

Table 7a — Landmark Culp-era Danaher acquisitions

Source: Danaher press releases and 10-K filings 2001-2015. Deal sizes approximate at close.

Culp specific contribution to DBS was to scale it from an operating tool to a strategic weapon. Under George Sherman (1990-2001) DBS was primarily a shop-floor discipline. Under Culp (2001-2014) DBS became the pre-close diligence framework, the post-close integration framework, and the ongoing operating cadence. Culp also formalized the DBS Office as a corporate-level function with a dedicated cadre of DBS coaches deployable to any newly acquired business or under-performing existing business. By 2014 Danaher had approximately 50 dedicated DBS coaches worldwide — the internal cadre that made the 100-day integration standard achievable at the acquisition cadence Culp was executing.

Culp stepped down as Danaher CEO in March 2014, succeeded by Tom Joyce. Culp joined the Wharton School faculty as a senior lecturer and served on several corporate boards. He was widely regarded across the American industrial community as one of the most operationally capable CEOs of his generation. That reputation made him the natural candidate for a specific, subsequent job: the turnaround of General Electric.

Table 7b — Culp Danaher-era metrics summary

Source: Danaher 10-K filings 2001-2014. Figures rounded for clarity.

DBS methodology applied at Fortune 10 scale — the three-way split

On October 1, 2018, H. Lawrence Culp Jr. was appointed CEO of General Electric — the first external CEO in GE 126-year history. Culp inherited a company under maximum operational duress: GE Power was working through the Alstom Power integration write-downs; GE Capital was being wound down under legacy insurance obligations; GE dividend had been cut twice; and the market capitalization had collapsed from a 2016 peak of approximately $280B to approximately $80B at the time of Culp appointment. The GE board's implicit theory in appointing Culp was that the operating discipline he had installed at Danaher — DBS methodology at scale — could be applied to GE. The subsequent six years supplied the largest-scale test of DBS methodology in American public equity, and, in this Institute read, the answer is that it worked, though not without controversy.

Culp tenure at GE has now delivered three specific structural outcomes and one operating-culture change. The three structural outcomes are (i) GE Capital wind-down completed, closing a decades-long tail of insurance liabilities that had constrained GE balance sheet; (ii) GE Healthcare (NYSE:GEHC) spun off in January 2023, taking approximately $19B of revenue and $50B of market cap with it; and (iii) GE Vernova (NYSE:GEV) spun off in April 2024, taking approximately $33B of revenue (Power, Wind, and Grid businesses) and $45B of initial market cap with it. The residual entity, GE Aerospace (NYSE:GE), consists of the commercial and defense aviation engines franchise.

Table 8a — Culp GE arc: from crisis 2018 to three-way split 2024

Source: GE, GE Healthcare, and GE Vernova 10-K filings 2018-2025.

The operating-culture change Culp installed at GE is the DBS methodology — kaizen, gemba walks, VSM, X-matrix — renamed Lean at GE to avoid overt Danaher branding. Culp personally led kaizen events at GE Aviation and GE Power in his first two years, physically walking the shop floor and running problem-solving sessions with front-line operators. The signal-to-noise effect was substantial: the visible presence of the CEO at gemba established that the operating discipline was not delegated. Culp continues this practice at GE Aerospace today. The 2024 GE Aerospace 10-K prominently references Lean as the enterprise operating system.

Not everyone reads Culp's GE tenure as a validation of DBS. Critics including corporate governance scholar Nell Minow and Barron's veteran columnist Andrew Bary have argued that the three-way split — GE Healthcare in January 2023, GE Vernova in April 2024, GE Aerospace as the residual — simply unlocked trapped conglomerate-discount value that any competent CEO could have engineered. Under this reading, DBS methodology was incidental; the value creation was primarily structural, not operational. The counter-argument has real merit: substantial sum-of-parts arbitrage clearly existed, and the market rewarded disaggregation regardless of operating discipline. But it under-weights two things. First, Culp took over in October 2018 with GE trading near a decade low precisely because prior management could not execute either the operational turnaround or the structural fix; the two challenges were entangled. Second, the mid-sequence operational metrics — GE Aerospace margins, GE Vernova order book, GE Healthcare growth — did materially improve during Culp's tenure ahead of the splits, not merely as a byproduct of them. Both readings can be partially true; the DBS-as-scaled-operating-system interpretation and the trapped-value-unlock interpretation are not mutually exclusive.

Table 8b — The three post-split GE entities today (mid-2026 approximate)

Source: GE Aerospace, GE HealthCare, GE Vernova FY2025 10-K filings; market caps approximate at July 2026.

Fortive 2016, Envista 2019, Veralto 2023 — the DBS-portability experiment

The most consequential structural feature of Danaher compounding record is that three transformative spinoffs — Fortive 2016, Envista 2019, Veralto 2023 — have each carried DBS methodology with them into an independent public company. Each spinoff is a natural experiment isolating the DBS operating discipline from Danaher portfolio construction. If DBS is the value-add rather than the specific businesses Danaher chose to buy, then the spun entities should reproduce the compounding pattern under their own operating cadence. If instead Danaher compounding was principally portfolio construction luck, the spun entities should regress. The three-spinoff record shows that DBS methodology has traveled with the spin.

Before 2016, a value investor could reasonably argue that Danaher compounding record was portfolio construction: the Rales brothers picked good businesses, held them at low leverage, and benefited from cyclical tailwinds in industrial and medtech markets. The three spinoffs disprove that argument. Each spinoff inherited a self-contained slice of the Danaher portfolio, carried DBS with it under a rebranded name, and has continued to execute its own serial-acquisition compounding since.

The Danaher spinoff mechanism is worth noting for its distinctness from the other three compounder archetypes. Berkshire has never executed a spinoff in six decades under Buffett — the model is permanent hold across the portfolio, and portfolio pruning happens (rarely) through sale rather than spin. Constellation Software has explicitly declared it will never divest a portfolio company, spin or otherwise. LVMH has occasionally divested maisons but has never executed a formal spin as portfolio pruning. Danaher alone uses spinoffs as the standard portfolio-pruning mechanism — non-core segments go to shareholders as standalone public entities rather than being sold or held indefinitely.

Table 9a — The three Danaher spinoffs at spin and today

Source: Fortive, Envista, Veralto 10-K filings; press releases at spin dates. Market caps approximate at July 2026.

Fortive (NYSE:FTV) took the industrial technology platform — Fluke, Tektronix, Gilbarco Veeder-Root, and the professional instrumentation businesses. It runs Fortive Business System (FBS) as its integration playbook. Since spin, Fortive has executed 30+ bolt-on acquisitions, deployed approximately $8B of capital, and grown market capitalization from $18B to $30B while returning approximately $1.8B in cumulative dividends. Fortive Business System (FBS) is a direct DBS methodology transplant, and Fortive operating discipline — managed by CEO Jim Lico, an ex-Danaher operator — has held.

Envista (NYSE:NVST) took the dental platform — Nobel Biocare, Ormco, KaVo Kerr, DEXIS. It runs Envista Business System (EBS). Envista has been the most challenged of the three spinoffs post-spin, hit by the dental-consumables cycle in 2023-2024 and the loss of a large Nobel Biocare distribution relationship. Market cap at July 2026 approximately $4B. The Envista experience illustrates that DBS is not sufficient to overcome secular category headwinds — DBS optimizes an operating position, it does not create a category tailwind.

Veralto (NYSE:VLTO), spun most recently in 2023, took the water quality (Hach, Trojan Technologies, ChemTreat, McCrometer) and product identification (Videojet, X-Rite, Pantone, Esko) businesses. It runs Veralto Enterprise System (VES). Veralto is the newest spinoff and is still in the early post-spin operating-independence period. Market cap at July 2026 approximately $22B; the water-quality secular tailwind (municipal water infrastructure, ESG-driven industrial water treatment) is strong.

Table 9b — Post-spinoff DBS discipline: bolt-on acquisitions each spinoff has executed

Source: Fortive, Envista, and Veralto acquisition disclosures 2016-2026; press releases and 10-K acquisition footnotes.

Table 9.1 — Danaher Nine-Quarter Free Cash Flow (Q1 2024 through Q1 2026, from Danaher 10-Q filings)

The standard Institute nine-quarter cash flow table. Traces the post-Veralto (September 2023) run rate of Danaher's continuing operations across the trailing nine quarters — revenue, EBITDA, capex, working-capital movement, operating cash flow, free cash flow, and FCF conversion. The window spans Q1 2024 (the first clean post-Veralto quarter with no Veralto contribution in the year-ago comparable) through Q1 2026 (most recent filed 10-Q as of memo date). Figures are approximate reconstructions from Danaher's 10-K and 10-Q disclosures; the model workbook (NINE_QUARTER_FCF tab) contains the point-estimate build. All figures in $B except conversion percentages.

Source and reconciliation: Danaher Corporation Form 10-Q filings for the periods ended March 31, 2024, June 30, 2024, September 30, 2024, March 31, 2025, June 30, 2025, September 30, 2025, and March 31, 2026; Form 10-K FY2024 (filed February 2025) for Q4 2024; Form 10-K FY2025 (filed February 2026) for Q4 2025 — all via SEC EDGAR CIK 0000313616. Because Danaher's 10-Qs disclose cash flow items only on a cumulative year-to-date basis, individual quarterly line items are derived by subtracting the prior cumulative disclosure from the current cumulative disclosure. Danaher does not report a company-defined Adjusted EBITDA; the EBITDA row is reconstructed from GAAP operating profit plus depreciation and amortization. Free cash flow is computed as operating cash flow less capital expenditures; Danaher does report a company-defined FCF number that reconciles closely to the OCF-minus-capex calculation shown here. Not investment advice.

What Table 9.1 says in one paragraph. FCF conversion above 20% quarterly is the DBS-driven cash productivity signal — a range Danaher has held with only limited slippage across the post-Veralto window. Q4 seasonality (Q4 2024 at 23.7%, Q4 2025 at 24.5%) reflects year-end billings, inventory drawdown, and receivables collection that recur every fiscal year and cannot be modeled as a permanent step-up. Across nine trailing quarters (Q1 2024 through Q1 2026) Danaher generated approximately $13.2B of operating cash flow and approximately $11.0B of free cash flow on approximately $54.3B of continuing-operations revenue — a ~20.3% conversion rate. The post-Veralto (September 2023) structure has held FCF/revenue in the 18-24% range across the aggregate of the Biotechnology, Life Sciences, and Diagnostics segments, evidencing that the DBS cash-productivity discipline survived the water-quality carve-out. This nine-quarter view is the practitioner's cash-flow-durability trace: reliable Q4 seasonality, no working-capital blowout, no capex step-up, no one-time distortion — the pattern of a mature operating-system compounder generating consistent, defensible free cash flow across the cycle.

The founders of a $185B compounder — how the wealth is structured

This section describes how founders of a $185B compounder are likely to structure their personal wealth. Steve and Mitchell Rales are famously private about their estate plans, so the specifics below reflect the trust and philanthropic vehicles that families at this wealth tier typically use — GRATs (grantor retained annuity trusts), IDGTs (intentionally defective grantor trusts), dynasty trusts, private foundations — not disclosed Rales-specific structures. Where the public record is silent, we describe the framework, not the details.

Steven Rales (born 1951) and Mitchell Rales (born 1956) are both approaching or past 70 as of 2026. Combined, they are estimated to be worth approximately $16-20B, with each brother individual net worth in the $8-10B range depending on the mark on their DHR, FTV, NVST, and VLTO positions and their diversified holdings. Steve Rales recent Forbes billionaire estimate is approximately $10B; Mitchell Rales is approximately $8B. Their positions in the four Danaher-lineage entities alone total in the ~$10B-plus range each. Both brothers have been executing a decade-long share divestiture through 10b5-1 pre-planned trading programs, most likely to fund estate-planning vehicles — GRATs, IDGTs, and dynasty trusts — as part of a systematic multi-generational wealth transfer.

This section is a structural discussion of the vehicles a family of the Rales wealth tier typically uses. It does not claim access to private trust documents. Where the specific structure is not on the public record, the discussion is generic to the wealth tier rather than specific to the Rales family. This is a case study in how founders of a $185B compounder actually structure their personal wealth — a topic worth understanding for estate practitioners even in the absence of proprietary access.

A material planning constraint at this tier is the generation-skipping transfer (GST) tax. The GST tax applies a 40% federal rate on transfers to grandchildren or later generations that bypass the intermediate generation, subject to the same lifetime exemption ($13.99M individual / $27.98M married in 2026 under the OBBBA rules). Because dynasty trusts are engineered to persist across multiple generations without repeat transfer-tax events, the sequencing and GST-exemption allocation on the front end largely determine how efficiently a Rales-scale dynasty structure compounds across the second and third generations. Full mechanics of GRATs, IDGTs, and dynasty trusts are covered in Estate Planning Decoded (Vol. XI of the Baratelli practitioner catalog).

Deductibility of contributions differs by foundation type. Operating foundations (like Glenstone, which directly operates the museum) permit up to 50% AGI cash deductions. Non-operating foundations (like the Rales Family Foundation for grants) cap cash deductions at 30% AGI. This distinction is common at the Rales wealth tier for philanthropic tax planning — families frequently pair an operating foundation for high-deduction current giving with a non-operating foundation for grant-making flexibility, and structure a charitable lead trust (CLT, charitable lead trust) into whichever vehicle produces the most efficient family and philanthropic result over the planning horizon.

Table 10a — The two Rales brothers publicly-observable structures

Source: Glenstone Museum public disclosures; Rales Family Foundation Form 990s (publicly available); Danaher, Fortive, Envista, Veralto Form 4 insider-transaction filings 2015-2025; Forbes billionaires' database. Institute reconstruction of aggregate 10b5-1 proceeds.

Table 10b — The estate-planning vehicles founders at the Rales wealth tier typically use

Source: Institute practitioner reconstruction based on generic wealth-tier structures. This table describes vehicles commonly used by founders at the Rales wealth level — it is not a claim of specific structures adopted by the Rales family.

Table 10c — Illustrative structural sequence at a Rales-scale founder retirement

The advisor coordination pattern discussed above — CFO, tax counsel, T&E attorney, investment adviser, art adviser — is fully specified in The Family Office Reference Guide, Chapter 2 (Team). Ongoing trust administration mechanics for corporate trustees are detailed in Trust Administration & Fiduciary Management (Vol. XV).

Where Danaher fits — Berkshire vs Constellation vs LVMH vs Danaher

The closing section positions Danaher explicitly as one of four legitimate compounder archetypes in public equity. Each archetype answers a slightly different question about what long-duration compounding looks like. Understanding the four archetypes as a taxonomy makes clear why Danaher compounding record has been genuine and reproducible, and why it is not directly comparable to Berkshire, Constellation, or LVMH. The four archetypes coexist — a practitioner reader building a durable compounder portfolio may reasonably want representation across more than one of the four.

Table 11a — The four compounder archetypes

Cross-links to companion Baratelli ledgers: Berkshire Portfolio Ledger; Constellation Portfolio Ledger; LVMH Maisons Ledger; Danaher Subsidiaries Ledger.

Table 11b — The four archetypes on eight dimensions

Source: Institute practitioner reconstruction. Market caps approximate at July 2026. TSR figures are directional illustrations; base years differ.

Table 11c — The DBS premium quantified: DBS-lineage entities vs. non-DBS peers

Source: DBS-lineage multiples from Danaher Q2 2026 10-Q and peer FY2025 disclosures. Non-DBS peer multiples reconstructed from Roper Technologies, IDEX, Ametek, Xylem, Pentair, Watts Water, Henry Schein, Patterson Companies FY2025 disclosures. DBS-premium quantification is an editorial reconstruction consistent with practitioner benchmarking; readers may reasonably discount the specific magnitude.

The four archetypes are not competitors. They answer different questions about capital allocation and operating philosophy. Danaher archetype — codified operating system installed at every acquisition — is the most reproducible of the four in the sense that a would-be operating-system compounder can, in principle, adopt DBS methodology and produce a similar (though not identical) record. Fortive, Envista, Veralto, GE (post-Culp), Colfax historical, Watts Water, and various other public and private industrial operators have adopted DBS-inflected operating discipline with measurable results. The Berkshire, Constellation, and LVMH archetypes are much harder to replicate because they depend on specific founder judgment (Buffett), specific market conditions (VMS niche availability at Constellation founding), or specific brand-heritage inventories (LVMH incomparable inventory of French and Italian luxury maisons).

Danaher is not alone in this archetype. Roper Technologies (~$50B market cap) explicitly credits DBS-inspired principles in its operating philosophy, and Fortive — Danaher's own 2016 spinoff — continues DBS in its own portfolio. This suggests the operating-system compounder is a legitimate category with multiple exemplars rather than a Danaher-specific phenomenon. Understanding the archetype means understanding a growing group of compounders, not just one.

Financials, valuation, SOTP, risks, and current-quarter print

This appendix preserves the practitioner-grade reference tables from the archived Danaher case memo — the standalone financials FY2022 through Q2 2026, the standalone valuation summary and peer comparables, the four-entity sum-of-the-parts, the three practitioner-relevant risks, and the FY2025 / Q1-Q2 2026 operating update. This material is directional and illustrative FY2025 approximate reporting; the working numbers are consistent with Danaher's public disclosure but rounded for narrative clarity. The main body of the memo (Sections 1-11) is the structural walk; this appendix is the reference-table companion for the practitioner who wants the financial print at a glance.

Appendix A — Post-spinoff Danaher segment mix and margins (FY2025)

Source: Danaher Corporation FY2025 Form 10-K segment disclosure. Revenue figures approximate FY2025 reporting rounded to the nearest ~$0.2B.

Appendix B — Danaher segment margins vs. peer group (illustrative)

Source: Danaher segment margins from FY2025 10-K; peer margins from Thermo Fisher, Bruker, Waters, Abbott, Roche, Siemens Healthineers, Sartorius Stedim, Repligen, and Merck KGaA Life Sciences FY2025 disclosures.

Appendix C — Cytiva + Aldevron integration status: the biggest single DBS test

Source: Danaher Q1 and Q2 2026 10-Qs; Danaher FY2025 10-K biotech segment disclosure; earnings call commentary from Rainer Blair (CEO) on Cytiva integration and bioprocessing order book. Pre-close baseline figures for Cytiva are from GE Healthcare Life Sciences pre-separation disclosure; Aldevron pre-close figures are Institute reconstruction. Operating margins are illustrative; direct segment-level Cytiva disclosure is not published as such by Danaher.

Appendix D — Danaher standalone financials FY2022 through Q2 2026 (illustrative)

Source: Danaher FY2022, FY2023, FY2024, and FY2025 10-K filings; Q1 and Q2 2026 10-Qs. FY2022 includes Veralto revenue (Veralto spun October 2023); FY2023 and forward are Danaher standalone post-Veralto.

Appendix E — Balance sheet summary and net debt trajectory

Source: Danaher balance-sheet disclosures FY2022-Q2 2026. Ratings from S&P Global and Moody's Investors Service.

Appendix F — Cash flow deployment FY2022 through H1 2026

Source: Danaher consolidated cash flow statements FY2022-Q2 2026. FY2023 M&A outflow reflects the Abcam close (~$5.7B).

Appendix G — Standalone Danaher valuation summary at July 2026

Source: Danaher Q2 2026 10-Q for share count and balance sheet; illustrative reference share price consistent with July 2026 trading range. Forward multiples are Institute reconstruction based on consensus-style FY2026E projections.

Appendix H — Peer comparables: Life Sciences / Diagnostics tools peer set (illustrative FY2025, July 2026 marks)

Source: Peer 10-Ks and 10-Qs for FY2025 and Q1/Q2 2026 disclosure; peer market-cap figures approximate at July 2026. Sartorius Stedim is presented in EUR (Euronext Paris); USD/EUR ~1.08.

Appendix I — DCF sensitivity: WACC and terminal growth (illustrative implied share price)

Source: Institute DCF construction on Danaher FY2026E free cash flow ~$6B growing at 5-year explicit-period rate declining from 7% to terminal growth. WACC calibration uses risk-free rate ~4.25%, equity risk premium ~5.5%, beta ~1.0.

Appendix J — Four-entity sum-of-the-parts: DHR + FTV + NVST + VLTO (illustrative July 2026)